Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (10) , 1108-1113
- https://doi.org/10.1016/s0002-9149(01)02043-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of percutaneous transluminal coronary angioplasty on coronary adenosine concentrations in humansEuropean Journal of Clinical Investigation, 2000
- The role of A3adenosine receptors in central regulation of arterial blood pressureBritish Journal of Pharmacology, 1998
- Relative Importance of Adenosine A1and A3Receptors in Mediating Physiological or Pharmacological Protection from Ischemic Myocardial Injury in the Rabbit HeartJournal of Molecular and Cellular Cardiology, 1998
- Mechanisms of cardiac pain during coronary angioplastyJournal of the American College of Cardiology, 1993
- Decreased sensitivity to adenosine in platelets from patients with familial hypercholesterolaemia—a change reversed by cholestyramine treatmentEuropean Journal of Clinical Investigation, 1993
- Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewireThe American Journal of Cardiology, 1993
- Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injuryCardiovascular Research, 1993
- Effects of short-term, diet-induced hypercholesterolemia on systemic hemodynamics, myocardial blood flow, and infarct size in awake dogs with acute myocardial infarction.Circulation, 1991
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986
- MEASUREMENT OF PAINPublished by Elsevier ,1974